On this episode of ID the Future, Dr. Michael Behe talks with Casey Luskin about recent findings that support his argument in The Edge of Evolution. Dr. Behe explains why Chloroquine, a drug that treats malaria, presents a good opportunity to study the limits of random mutation and natural selection, and how his conclusions inspired so much backlash — including misrepresentation of his argument — from his critics.
On this episode of ID the Future, Nancy Pearcey, professor and scholar in residence at Houston Baptist University, tells more of the political history...
On this episode of ID the Future, biologist Ann Gauger responds to a negative review of the new Crossway anthology Theistic Evolution: A Scientific,...
On this ID the Future from the vault, Lehigh University biologist Michael Behe discusses his peer-reviewed scientific paper in the Quarterly Review of Biology....
